The Times of India lauds new efforts in the subcontinent to encourage the growth of its biotech industry. Under new legislation, the country's department of biotechnology is now setting aside 30 percent of its annual budget to fund public/private collaborations on new drug development. A new council has been created to help coordinate efforts between academics and biotech companies and a new regulatory body has been created. India has a shortage of trained regulators, but the Times editorial suggests that the FDA may step in to help train personnel.
- read the editorial in the Times of India